This News From Novo: A Warning for Eli Lilly Shareholders
A GLP-1 drug race is moving from injections to pills, reshaping the landscape for Novo Nordisk and Eli Lilly. Here’s ...
Find out what makes a good retirement strategy and how you can build wealth for a secure future. Implement these tips to enhance your retirement plan.
18,857 articlesA GLP-1 drug race is moving from injections to pills, reshaping the landscape for Novo Nordisk and Eli Lilly. Here’s ...
Mungo Homes has named Ric Rojas president of its newly formed Mid-Atlantic region, a move designed to accelerate grow...
A single momentum-driven AI ETF is gaining attention as capex in AI hardware expands. The strategy aims to ride leade...
Indianapolis offers affordable entry and steady rental demand for buyers, yet pockets of foreclosures add risk. This ...
Cathie Wood's Ark Invest has been quietly loading up on Nvidia this week. Here are three solid reasons why her buying...
Tilray shifted from cannabis focus to a BrewDog partnership in search of diversification. But early UK sales data rai...
A new crypto ETF offering 2x daily exposure to a Bitcoin strategy has collapsed, leaving early investors with severe ...
Taylor Morrison has named Mike Carlo to lead its Sarasota division, tapping a veteran of more than 25 years in homebu...
Yum! Brands is selling Pizza Hut in two moves, reshaping its portfolio. This could boost balance sheet strength and s...
A strong earnings backdrop and improving fundamentals may be signaling a shift for Micron stock. This guide breaks do...
Dividend-focused investors face a unique puzzle with Boeing: potential for future income vs. exposure to cyclic risk....
The GLP-1 wave has traders buzzing. While Lilly and Novo Nordisk hold steady as reliable bets, smart portfolios tap i...